Cell therapy
Showing 9951 - 9975 of >10,000
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric Trial in Denmark,
Recruiting
- Acute Lymphoblastic Leukemia
- +4 more
-
Copenhagen, Denmark
- +16 more
Jan 26, 2022
Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)
Terminated
- Mantle Cell Lymphoma
- +4 more
- cellular immunotherapy
-
Providence, Rhode Island
- +1 more
Feb 23, 2022
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea:
Recruiting
- Obstructive Sleep Apnea
- +2 more
- Continuous Positive Airway Pressure
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 20, 2022
Ulcerative Colitis Flare Trial (MitoQ, Placebo)
Not yet recruiting
- Ulcerative Colitis Flare
- MitoQ
- Placebo
- (no location specified)
Oct 5, 2021
Diabetes, Type 2 Trial in Beijing (SAL067, Placebo)
Completed
- Diabetes Mellitus, Type 2
- SAL067
- Placebo
-
Beijing, Beijing, ChinaPeking University Hospital
Mar 24, 2023
Allogeneic SCT for CML, TKI Failure After TKI Failure
Unknown status
- Chronic Myeloid Leukemia
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 29, 2020
Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +6 more
- (no location specified)
Dec 28, 2022
Pediatric Cancer, Sleep Trial in Battalgazi (Aromatherapy, music concert)
Active, not recruiting
- Pediatric Cancer
- Sleep
- Aromatherapy
- music concert
-
Battalgazi, Malatya, TurkeyInonu University
Dec 16, 2021
Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Middletown, New Jersey
- +5 more
Aug 17, 2023
Retention Rate of Acalabrutinib in a Non-interventional Setting
Recruiting
- Chronic Lymphocytic Leukaemia (CLL)
-
Zittau, GermanyResearch Site
Jan 12, 2023
Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- (no location specified)
Sep 19, 2023
Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV
Recruiting
- HIV/AIDS
- No intervention
-
Rome, ItalyInfectious Dermatology STI Unit San Gallicano Dermatologic Insti
Mar 23, 2022
First-Line Serplulimab Plus Chemotherapy in Treatment of
Not yet recruiting
- Lung Cancer
- Serplulimab plus chemotherapy
- (no location specified)
May 16, 2023
Complications and Recurrences After Mohs Micrographic Surgery
Recruiting
- Skin Cancer
- +9 more
- Mohs surgery
- Slow Mohs surgery
-
Maastricht, NetherlandsMaastricht University Medical Center+
Aug 23, 2023
Infection, Human Immunodeficiency Virus, HIV, Arthralgia Trial in Orel, St. Petersburg, Madrid (DTG 50 mg /ABC 600 mg /3TC 300
Completed
- Infection, Human Immunodeficiency Virus
- +2 more
- DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets
-
Orel, Russian Federation
- +2 more
Sep 9, 2022
Cardiovascular Diseases, CHF, Dilated Cardiomyopathy Trial in Nanjing (hiPSC-CM therapy)
Recruiting
- Cardiovascular Diseases
- +2 more
- hiPSC-CM therapy
-
Nanjing, Jiangsu, ChinaHelp Therapeutics
Mar 24, 2022
ALL Ph Positive Trial in Italy (Total therapy approach)
Active, not recruiting
- ALL Ph Positive
- Total therapy approach
-
Rionero in Vulture, Potenza, Italy
- +50 more
Oct 7, 2020
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)
Recruiting
- Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Columbus (Counseling, Dietary Counseling and Surveillance,
Active, not recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Counseling
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 5, 2023
Coronary Artery Disease, Atherosclerosis of Coronary Artery Trial in Nijmegen (Evolocumab 140 MG/ML [Repatha])
Recruiting
- Coronary Artery Disease
- Atherosclerosis of Coronary Artery
- Evolocumab 140 MG/ML [Repatha]
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jan 11, 2022
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Allogeneic Hematopoietic Stem Cell Transplantation
- +15 more
-
Birmingham, Alabama
- +550 more
Jan 28, 2023